Filing Manager
Samsara BioCapital, L.P.
Reporting Manager
Srinivas Akkaraju
Symbol
KLRS
Shares outstanding
22,926,692 shares
Disclosed Ownership
12,953,581 shares
Ownership
56%
Form type
SCHEDULE 13D/A
Filing time
22 Dec 2025, 16:17:04 UTC
Date of event
22 Dec 2025
Previous filing
25 Mar 2025

Quoteable Key Fact

"Samsara BioCapital, L.P. disclosed 56% ownership in KALARIS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (KLRS) on 22 Dec 2025."

Quick Takeaways

  • Samsara BioCapital, L.P. filed SCHEDULE 13D/A for KALARIS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (KLRS).
  • Disclosed ownership: 56%.
  • Date of event: 22 Dec 2025.

What Changed

  • Previous schedule filing date: 25 Mar 2025.
  • Current filing was accepted on 22 Dec 2025, 16:17.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Samsara BioCapital, L.P. 50% 11,448,081 0 11,448,081 /s/ Srinivas Akkaraju By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member 0001699737
Samsara BioCapital GP, LLC 50% 11,448,081 0 11,448,081 /s/ Srinivas Akkaraju By Srinivas Akkaraju, Managing Member 0001888829
Samsara Opportunity Fund, L.P. 6.5% 1,500,000 0 1,500,000 /s/ Srinivas Akkaraju By Samsara Opportunity Fund GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member 0002086193
Samsara Opportunity Fund GP, LLC 6.5% 1,500,000 0 1,500,000 /s/ Srinivas Akkaraju By Srinivas Akkaraju, Managing Member 0002086456
Srinivas Akkaraju 56% 12,953,581 5,500 12,948,081 /s/ Srinivas Akkaraju Srinivas Akkaraju 0001253170